Delirium Tied to Increased Risk of Death in Critically Ill With Cancer
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.
Combination avelumab and axitinib has shown long-term activity in previously untreated patients with advanced renal cell carcinoma.
Black cancer patients are less likely than their White counterparts to receive shorter radiotherapy regimens, a study suggests.
Sexual function less likely to be assessed in women versus men undergoing brachytherapy for genitourinary cancers
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
A team of investigators examined the financial burden of breast, lung, colorectal, and prostate cancers for nonelderly adults with private insurance.
Adjuvant pembrolizumab could be a new standard of care for patients with clear cell renal cell carcinoma at increased risk of recurrence after nephrectomy, according to researchers.
Nivolumab plus ipilimumab did not prolong disease-free survival, and 43% of patients discontinued treatment due to toxicities.
The PFS benefit was driven primarily by patients with intermediate-risk disease.